Works matching IS 00099236 AND DT 2009 AND VI 85 AND IP 5
Results: 27
Assessment of MAO-B Occupancy in the Brain With PET and [<sup>11</sup>C]-L-Deprenyl-D<sub>2</sub>: A Dose-Finding Study With a Novel MAO-B Inhibitor, EVT 301.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 506, doi. 10.1038/clpt.2008.241
- By:
- Publication type:
- Article
Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 513, doi. 10.1038/clpt.2008.250
- By:
- Publication type:
- Article
Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 520, doi. 10.1038/clpt.2008.251
- By:
- Publication type:
- Article
Pro32Thr Polymorphism of Inosine Triphosphate Pyrophosphatase Gene Predicts Efficacy of Low-Dose Azathioprine for Patients With Systemic Lupus Erythematosus.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 527, doi. 10.1038/clpt.2008.261
- By:
- Publication type:
- Article
Heart Rhythm Disturbances Associated With Rupatadine: A Case Series From the Spanish and Portuguese Pharmacovigilance Systems.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 481, doi. 10.1038/clpt.2008.269
- By:
- Publication type:
- Article
Pharmacogenetics-Based Population Pharmacokinetic Analysis of Efavirenz in HIV-1-Infected Individuals.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 485, doi. 10.1038/clpt.2008.271
- By:
- Publication type:
- Article
Nanomedicine and Society.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 466, doi. 10.1038/clpt.2008.276
- By:
- Publication type:
- Article
The Effect of Activated Charcoal on Drug Exposure in Healthy Volunteers: A Meta-Analysis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 501, doi. 10.1038/clpt.2008.278
- By:
- Publication type:
- Article
Delivery of Biologics in Cardiovascular Regenerative Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 548, doi. 10.1038/clpt.2008.295
- By:
- Publication type:
- Article
Small Solutions for Big Problems: The Application of Nanoparticles to Brain Tumor Diagnosis and Therapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 531, doi. 10.1038/clpt.2008.296
- By:
- Publication type:
- Article
Ophthalmic Drug Delivery: Development and Regulatory Considerations.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 539, doi. 10.1038/clpt.2008.297
- By:
- Publication type:
- Article
Inappropriate Medications and Adverse Drug Reactions in the Elderly.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Studies Should Be Controlled, Randomized, and Blinded.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 461, doi. 10.1038/clpt.2009.13
- By:
- Publication type:
- Article
Response to “Inappropriate Medications and Adverse Drug Reactions in the Elderly”.
- Published in:
- 2009
- By:
- Publication type:
- Letter
CORRIGENDUM: PI-34: An Analysis of Subjects in Clinical Trials Who, After Dosing, Report Predose Adverse Events and Abnormalities in Their Medical Histories.
- Published in:
- 2009
- Publication type:
- Correction Notice
Combination Products Regulation at the FDA.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 468, doi. 10.1038/clpt.2009.28
- By:
- Publication type:
- Article
Methods for Female Contraception: A Model for Innovation in Drug Delivery Systems.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 553, doi. 10.1038/clpt.2009.29
- By:
- Publication type:
- Article
Drug Delivery in the Twenty-First Century: A New Paradigm.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
How Well Does Blinding Work in Randomized Controlled Trials?: A Counterpoint.
- Published in:
- 2009
- By:
- Publication type:
- Opinion
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 449, doi. 10.1038/clpt.2009.36
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 456, doi. 10.1038/clpt.2009.37
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 458, doi. 10.1038/clpt.2009.38
- Publication type:
- Article
UGT Genotype May Contribute to Adverse Events Following Medication With Mycophenolate Mofetil in Pediatric Kidney Transplant Recipients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 495, doi. 10.1038/clpt.2009.3
- By:
- Publication type:
- Article
CORRIGENDUM: Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus.
- Published in:
- 2009
- Publication type:
- Correction Notice
The Next Generation of Drug-Delivery Microdevices.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 544, doi. 10.1038/clpt.2009.4
- By:
- Publication type:
- Article
A Critical Appraisal of the Safety and Efficacy of Drug-Eluting Stents.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 474, doi. 10.1038/clpt.2009.8
- By:
- Publication type:
- Article
Predictive Biomarkers in the Development of Oncology Drugs: A Therapeutic Industry Perspective.
- Published in:
- Clinical Pharmacology & Therapeutics, 2009, v. 85, n. 5, p. 535, doi. 10.1038/clpt.2009.9
- By:
- Publication type:
- Article